Molecular Templates, Inc. - FORM 10-K - EX-23.2 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - March 15, 2012

Attached files

file filename
10-K - FORM 10-K - Molecular Templates, Inc.d269230d10k.htm
EX-23.1 - CONSENT OF ERNST & YOUNG LLP - Molecular Templates, Inc.d269230dex231.htm
EX-10.2 - 2004 AMENDED AND RESTATED EQUITY INCENTIVE PLAN (AS AMENDED ON MAY 19, 2010) - Molecular Templates, Inc.d269230dex102.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 15D-14 OF THE SECURITIES AND EXCHANGE ACT OF 1934 - Molecular Templates, Inc.d269230dex311.htm
EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - Molecular Templates, Inc.d269230dex321.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 15D-14 OF THE SECURITIES AND EXCHANGE ACT OF 1934 - Molecular Templates, Inc.d269230dex312.htm
EX-32.2 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - Molecular Templates, Inc.d269230dex322.htm
EXCEL - IDEA: XBRL DOCUMENT - Molecular Templates, Inc.Financial_Report.xls

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-174844, No. 333-169689, 333-162719 and 333-153475) and Registration Statement on Form S-8 (No. 333-173047, No. 333-167260, 333-164865, No. 333-156733, No. 333-126276, No. 333-134598, and No. 333-143130) of Threshold Pharmaceuticals, Inc. of our report dated March 24, 2011 relating to the consolidated financial statements, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

San Jose, California

March 15, 2012

Stock widget

Investing forum

Molecular Templates, Inc. Reports